11/19/2024 8:48 PM | Kelly Timothy Edwin (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 8:50 PM | Mastrocola Lauren (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2024 8:30 PM | Mastrocola Lauren (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2024 8:30 PM | Nemiroff Alex (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 6:53 PM | Point72 Asset Management, L.P. (Filed by) Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/14/2024 4:50 PM | Praxis Precision Medicines (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024 4:46 PM | Praxis Precision Medicines (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
|
11/14/2024 2:08 PM | Cormorant Asset Management, LP (Filed by) Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/14/2024 1:32 PM | Mastrocola Lauren (Reporting) Praxis Precision Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 12:45 PM | Nemiroff Alex (Reporting) Praxis Precision Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 8:23 AM | Praxis Precision Medicines (Subject) Verition Fund Management LLC (Filed by)
| Form SC 13G/A | |
11/12/2024 12:29 PM | Capital Research Global Investors (Filed by) Praxis Precision Medicines (Subject)
| Form SC 13G | |
11/12/2024 8:35 AM | Adage Capital Management, L.P. (Filed by) Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/06/2024 6:59 AM | Praxis Precision Medicines (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024 6:57 AM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/22/2024 2:24 PM | BlackRock, Inc. (Filed by) Praxis Precision Medicines (Subject)
| Form SC 13G | |
10/15/2024 7:00 AM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 4:42 PM | PERCEPTIVE ADVISORS LLC (Filed by) Praxis Precision Medicines (Subject)
| Form SC 13G | |
09/03/2024 7:15 AM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 6:20 AM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 6:22 AM | Praxis Precision Medicines (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024 8:00 PM | Kelly Timothy Edwin (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2024 8:01 PM | Mastrocola Lauren (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2024 8:02 PM | Nemiroff Alex (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2024 8:03 PM | Praxis Precision Medicines (Issuer) Souza Marcio (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 8:31 PM | Praxis Precision Medicines (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
06/06/2024 5:55 PM | Norden Gregory (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 5:55 PM | Praxis Precision Medicines (Issuer) YOUNG WILLIAM D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 5:55 PM | Cudkowicz Merit Ester (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 5:56 PM | Chodakewitz Jeffrey (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 5:56 PM | MITCHELL DEAN J (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 5:56 PM | DeSimone Jill (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 4:09 PM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 7:10 AM | Praxis Precision Medicines (Issuer) Souza Marcio (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 7:10 AM | Kelly Timothy Edwin (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/13/2024 7:18 AM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 7:21 AM | Praxis Precision Medicines (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024 6:46 AM | Praxis Precision Medicines (Filer)
| Form DEF 14A | |
04/26/2024 6:47 AM | Praxis Precision Medicines (Filer)
| Form DEFA14A | |
03/29/2024 3:29 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
03/29/2024 3:30 PM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
This Bull Market Indicator called NVDA at $116 (Ad) Every now and again we find an investment idea so incredible we can’t help but share.
And today is one of those rare days…
Except, today we won't be giving you insight on any one particular stock…
But rather, insight on a revolutionary new stock picking indicator…
In fact, within the last year, this indicator has become famous for a multitude of reasons…
But one of the biggest was because of the buy signal it issued on October 18th, 2022.
In fact, on that very day, it said to buy NVDA at $116.37…
Anyone who did would be sitting on a tremendously large return today…
But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here |
03/27/2024 3:49 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
03/26/2024 6:01 AM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2024 11:15 PM | Praxis Precision Medicines (Filer)
| Form EFFECT | |
03/05/2024 8:08 AM | Praxis Precision Medicines (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/05/2024 6:33 AM | Praxis Precision Medicines (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024 6:12 AM | Praxis Precision Medicines (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/05/2024 6:13 AM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 7:45 PM | Praxis Precision Medicines (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024 11:21 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by) Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/14/2024 7:55 AM | Praxis Precision Medicines (Subject) Verition Fund Management LLC (Filed by)
| Form SC 13G | |
02/13/2024 6:08 PM | Avidity Partners Management LP (Filed by) Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/09/2024 4:21 PM | Blackstone Holdings I/II GP L.L.C. (Filed by) Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/07/2024 6:46 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/06/2024 4:10 PM | KINGDON CAPITAL MANAGEMENT, L.L.C. (Filed by) Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/05/2024 8:13 AM | Praxis Precision Medicines (Subject) SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G/A | |
01/17/2024 3:47 PM | Mastrocola Lauren (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:48 PM | Nemiroff Alex (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:49 PM | Praxis Precision Medicines (Issuer) Souza Marcio (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:51 PM | Kelly Timothy Edwin (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 4:20 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
01/12/2024 4:23 PM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/11/2024 5:01 AM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2024 4:28 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
01/10/2024 3:10 PM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 8:08 PM | Mastrocola Lauren (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 8:09 PM | Praxis Precision Medicines (Issuer) Souza Marcio (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 8:10 PM | Nemiroff Alex (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 8:11 PM | Kelly Timothy Edwin (Reporting) Praxis Precision Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 4:19 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
12/07/2023 4:23 PM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/01/2023 3:33 PM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 3:30 PM | Praxis Precision Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |